340B Supports Essential Hospital Services

Blog

Millions of Americans worry about the high costs of life-saving prescription drugs. That’s why 25 years ago, Congress created the 340B Drug Pricing Program to help hospitals expand access to prescription drugs and support essential services for our most vulnerable patients.

The program constitutes less... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicare, access, regulation

CMS issues final outpatient PPS rule

AHA News

The Centers for Medicare & Medicaid Services Nov. 1 announced it will update the hospital outpatient prospective payment system rates by 1.35% in calendar year 2018 compared to CY 2017. The rule also finalizes CMS’s proposal to drastically cut Medicare payment for drugs that are acquired under the 340B... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicare, regulation, home health

Hearing highlights benefits of 340B Drug Pricing Program

AHA News Now

The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care organizations at... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicare, Medicaid, drug prices

Senators urge CMS to consider stakeholders' concerns on 340B proposal

AHA News

Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services (CMS) to “carefully consider stakeholder feedback” before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “The long-term success of the 340B program... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, advocacy, access

57 senators urge CMS to consider feedback before finalizing 340B proposal

AHA News Now

Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services to “carefully consider stakeholder feedback" before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. "The long-term success of the 340B program is... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation

AHA, AAMC express support for 340B program

AHA News Now

The 340B Drug Pricing Program “has enabled hospitals and health systems to support and expand access and services consistent with their mission and the program’s original and ongoing charge,” the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce Committee... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

What's Next in the Health Care Debate?

Blog

Once again, the Senate attempted to pass a proposal to repeal and replace significant parts of the Affordable Care Act. Once again, it met defeat – and we are grateful.

But this fight is not over. America’s hospitals and health systems must stay vigilant and continue to make the case to protect coverage... read more

Topic: Advocacy and Public Policy
Tags: Drug Pricing Program, Medicare, Coverage, advocacy, Medicaid, access

Majority of House members urge CMS to abandon proposal to cut 340B program

AHA News Now

Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “Given the important role that the 340B program plays in our... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

HRSA delays to July effective date of 340B drug ceiling price rule

AHA News Now

The Health Resources and Services Administration today delayed to July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. “We are delaying the effective date of the Jan. 5, 2017, final rule to July 1, 2018, because the delay will... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

House lawmakers urge CMS to drop planned 340B cuts

AHA News

A bipartisan group of 228 House lawmakers yesterday urged the Centers for Medicare & Medicaid Services (CMS) to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program.

“Given the important role that the 340B program plays in our communities, we... read more

Topic: Advocacy and Public Policy
Tags: Drug Pricing Program, advocacy

Keyword Search

Date